Retinal & Vitreoretinal Devices
Vitrectomy systems, retinal laser platforms, intravitreal injection equipment, and imaging devices used in posterior segment surgical and medical procedures.
Market snapshot
These figures describe Ophthalmology & Vision Devices (4.8.9), the segment that Retinal & Vitreoretinal Devices sits within — not Retinal & Vitreoretinal Devices on its own.
- Market size
- ~$6.5B
- Growth
- ~1.1%CAGR (2017–22, nominal)
- Companies
- ~450
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 339115 (Ophthalmic Goods Manufacturing) — includes broader ophthalmic goods.
Business model & economics
Revenue model
Implants, equipment, and consumables for eye care
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 18–28%
- Capex intensity
- High
procedure-driven implants and consumables
Characteristics
- Aging-driven cataract and retinal procedure growth.
- Premium IOLs a higher-value growth area.
- Led by Alcon and J&J Vision.
Geographic concentration
Ophthalmology and vision-device manufacturing over-indexes by employment in Minnesota, Arkansas, Nebraska, and Georgia, reflecting concentrated device-maker operations.
U.S. Census Bureau — 2022 County Business Patterns (employment by state), NAICS 339115. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Ophthalmic-device strategics
- Diversified medtech platforms
- VC-backed innovators
What’s driving deals
- Premium-IOL and MIGS innovation.
- Aging-demographic procedure demand.
- Acquisition of ophthalmic innovation.
Find Retinal & Vitreoretinal Devices acquisition targets
Search Acquisera’s index for companies classified under Retinal & Vitreoretinal Devices (4.8.9.5) and build a targeted deal pipeline.
Search companies